MedPath

Effect Of Nigella Sativa Oil for the Treatment of Hypertension

Not Applicable
Active, not recruiting
Conditions
Hypertension
Registration Number
NCT07055763
Lead Sponsor
Superior University
Brief Summary

My research explores the antihypertensive effects of Nigella sativa (black seed) oil in managing high blood pressure. Hypertension is a growing global health concern, often insufficiently controlled by standard medications. Nigella sativa, known for its bioactive compound thymoquinone, possesses antioxidant, anti-inflammatory, and vasodilatory properties, making it a potential natural remedy for blood pressure regulation.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Adults aged 30 to 70 years
  • Diagnosed with mild to moderate hypertension (BP ≥140/90 mmHg)
  • Willing to participate and provide written informed consent
  • Not currently on any herbal or nutritional supplements
Exclusion Criteria
  • History of smoking or alcohol consumption
  • Pregnant, postmenopausal, or breastfeeding women
  • Use of dietary supplements or medications containing antioxidants, caffeine, estrogen, or steroids
  • Individuals engaging in regular vigorous physical exercise
  • Those adding extra salt to their meals
  • Known allergy to Nigella sativa or black seed oil

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Structured Patient History Questionnaire12 Months

A pre-designed, structured questionnaire will be used at baseline to collect demographic information, medical history, medication use, dietary habits, and lifestyle factors. This is a qualitative tool without a scoring system but is essential for eligibility confirmation and contextual analysis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bahria Town

🇵🇰

Lahore, Punjab, Pakistan

Bahria Town
🇵🇰Lahore, Punjab, Pakistan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.